MANORAMA Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹363 Cr
verified against source
Revenue YoY
73.3%
reported change
EBITDA
₹98 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Manorama Industries delivered exceptional Q3 FY26 results with INR 363 crore revenue (+73.3% YoY), driven by enhanced value-added product mix and optimized utilization of the upgraded fractionation facility. EBITDA of INR 98 crore maintained robust 27.1% margins, while PAT of INR 68 crore translated to 18.8% net margin. The company raised FY26 revenue guidance to INR 1,300 crore from INR 1,150 crore, reflecting strong demand from chocolate, confectionery, and cosmetic sectors globally. A major INR 460 crore capex program over 2-3 years was announced, targeting 75,000 MT cocoa butter alternatives capacity, 75,000 MT fractionation, 90,000 MT refinery, and a Burkina Faso backward integration facility. Current 85% capacity utilization and 30% debottlenecking expansion to 52,000 MT support near-term growth. Management guides 30%+ revenue growth for FY27 and expects asset turns exceeding 5x on new investments. Gross margin normalized to 44.3% from prior quarter's 52.8%, attributed to seasonal fluctuations and byproduct realizations rather than structural issues. Key risks include raw material price volatility and execution risk on the large multi-project capex rollout.
Colored figures show movement against the previous available record.
Guidance to track
- Revised upward from INR 1,150 crore, driven by strong Q3 performance and sustained demand momentum across key customer segments.
- Management indicated the existing 40,000MT capacity with 15% additional headroom and 30% debottlenecking to 52,000MT provides 40-50% growth potential for next 1-2 years.
- Out of total INR 460 crore capex, approximately INR 300-330 crore is allocated to forward integration projects (CBA, fractionation, refinery) with targeted asset turns exceeding 5x.
- Current 25-27% margin range confirmed as sustainable baseline; management working to improve over medium-to-longer term through forward/backward integration projects.
Risks flagged
- GP margin declined to 44.3% from 52.8% in Q2 due to raw material cost fluctuations and byproduct realization changes, though management maintains EBITDA margins are stable at 25-27%.
- INR 460 crore capex spanning 4 projects (CBA, fractionation, refinery, Burkina Faso) across India and West Africa over 2-3 years requires significant coordination, funding, and execution capability.
- Cocoa prices corrected 60%+ in a year; analyst questioned whether CBE products would see price compression similar to cocoa butter (which fell from $25,000-30,000/MT peaks). Management maintains cost-plus model insulates pricing, but commodity linkage for CBE not fully resolved.
- Brazil partnership with Decel Group, expected to deliver 2,000+ MT in FY26, contributed only 'minor' amounts in Q3 with full revenue ramp unclear. Long-term roadmap for revenue contribution was not quantified.
Key quotes
- We have reported revenues of INR 363 crores which reflects a remarkable year-on-year growth of 73.3%. This strong performance can be attributed to several key factors including an enhanced mix of value added products, the optimized utilization of our newly upgraded fractionation facility and our commitment to operational excellence.
- Our backward integration from procurement to research and development to supercritical fractionation provides us with unparallel control over quality, cost, supply stability and the confidence of our worldwide customers. This strategic approach positions us as a trusted partner for our customers in the chocolate, confectionary and cosmetic industries.
- We are primarily relying on our internal cash accruals which are very strong and sufficient enough to support our planned projects over the next two to three years. We already have begun deploying these funds. We already have spent 52 odd crores towards this capex plan.
Research modules
